Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 78,762,953
- Total 13F shares
- 6,249,494
- Share change
- -58,789
- Total reported value
- $14,377,182
- Price per share
- $2.28
- Number of holders
- 27
- Value change
- -$299,603
- Number of buys
- 7
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 28617K101?
CUSIP 28617K101 identifies ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28617K101:
Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
3%
|
2,326,710
|
$6,422,000 | — | 30 Sep 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
1.6%
|
1,223,500
|
$3,377,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.86%
|
679,243
|
$1,875,000 | — | 30 Sep 2022 | |
| Woodline Partners LP |
13F
|
Company |
0.66%
|
516,675
|
$1,426,000 | — | 30 Sep 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.48%
|
375,000
|
$1,035,000 | — | 30 Sep 2022 | |
| CM Management, LLC |
13F
|
Company |
0.31%
|
245,000
|
$676,000 | — | 30 Sep 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.28%
|
221,830
|
$612,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
129,465
|
$357,000 | — | 30 Sep 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.11%
|
87,286
|
$241,000 | — | 30 Sep 2022 | |
| Eversept Partners, LP |
13F
|
Company |
0.09%
|
67,743
|
$186,971 | — | 30 Sep 2022 | |
| JMAC ENTERPRISES LLC |
13F
|
Company |
0.07%
|
54,538
|
$151,000 | — | 30 Sep 2022 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
0.06%
|
51,149
|
$141,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.06%
|
49,365
|
$136,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
44,692
|
$123,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.05%
|
42,200
|
$116,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
31,873
|
$88,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
30,053
|
$83,000 | — | 30 Sep 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
29,737
|
$82,000 | — | 30 Sep 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
22,050
|
$61,000 | — | 30 Sep 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
17,950
|
$50,000 | — | 30 Sep 2022 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.02%
|
16,726
|
$46,000 | — | 30 Sep 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
1,666
|
$4,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,133
|
$3,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,014
|
$3,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
537
|
$1,000 | — | 30 Sep 2022 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
339
|
$1,000 | — | 30 Sep 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1
|
$1,000 | — | 30 Sep 2022 |
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q4 2022
As of 31 Dec 2022,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,249,494 shares.
The largest 10 holders included
BVF INC/IL, Cormorant Asset Management, LP, VANGUARD GROUP INC, Woodline Partners LP, Ensign Peak Advisors, Inc, CM Management, LLC, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Eversept Partners, LP, and JMAC ENTERPRISES LLC.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
26
Q4 2022 holders
27
Holder diff
1
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.